SUSMED,Inc. (TYO:4263)
557.00
-3.00 (-0.54%)
May 2, 2025, 3:30 PM JST
SUSMED,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Cash & Equivalents | 4,557 | 4,846 | 5,048 | 4,904 | 1,626 | 366 |
Cash & Short-Term Investments | 4,557 | 4,846 | 5,048 | 4,904 | 1,626 | 366 |
Cash Growth | -10.31% | -4.00% | 2.94% | 201.60% | 344.26% | - |
Accounts Receivable | 19 | 10 | 10 | 9 | 5 | 1 |
Other Receivables | 6 | 9 | - | - | 11 | 2 |
Receivables | 25 | 19 | 10 | 9 | 16 | 3 |
Prepaid Expenses | 47 | 30 | 25 | 21 | 26 | 7 |
Other Current Assets | 3 | 3 | 2 | 1 | 6 | 2 |
Total Current Assets | 4,632 | 4,898 | 5,085 | 4,935 | 1,674 | 378 |
Long-Term Investments | 34 | 25 | 8 | 8 | - | 3 |
Other Intangible Assets | 16 | 8 | 7 | - | - | - |
Other Long-Term Assets | 1 | 1 | 1 | - | - | - |
Total Assets | 4,683 | 4,932 | 5,101 | 4,943 | 1,674 | 381 |
Accrued Expenses | 3 | 1 | 1 | 1 | - | - |
Current Income Taxes Payable | 65 | 67 | 82 | 70 | 81 | 15 |
Current Unearned Revenue | - | - | - | - | 6 | 4 |
Other Current Liabilities | 271 | 253 | 141 | 16 | 9 | 3 |
Total Current Liabilities | 339 | 321 | 224 | 87 | 96 | 22 |
Other Long-Term Liabilities | 7 | 7 | 7 | 6 | 1 | 4 |
Total Liabilities | 346 | 328 | 231 | 93 | 97 | 26 |
Common Stock | 97 | 80 | 40 | 1,853 | 100 | 411 |
Additional Paid-In Capital | 5,439 | 5,423 | 5,383 | 3,509 | 1,756 | 401 |
Retained Earnings | -1,233 | -920 | -562 | -511 | -278 | -458 |
Comprehensive Income & Other | 34 | 21 | 9 | -1 | -1 | 1 |
Shareholders' Equity | 4,337 | 4,604 | 4,870 | 4,850 | 1,577 | 355 |
Total Liabilities & Equity | 4,683 | 4,932 | 5,101 | 4,943 | 1,674 | 381 |
Net Cash (Debt) | 4,557 | 4,846 | 5,048 | 4,904 | 1,626 | 366 |
Net Cash Growth | -10.31% | -4.00% | 2.94% | 201.60% | 344.26% | - |
Net Cash Per Share | 272.01 | 290.30 | 307.76 | 333.99 | 127.09 | 31.81 |
Filing Date Shares Outstanding | 16.79 | 16.74 | 16.55 | 16.11 | 12.79 | 11.51 |
Total Common Shares Outstanding | 16.79 | 16.74 | 16.55 | 16.11 | 12.79 | 11.51 |
Working Capital | 4,293 | 4,577 | 4,861 | 4,848 | 1,578 | 356 |
Book Value Per Share | 258.25 | 275.06 | 294.25 | 301.11 | 123.26 | 30.85 |
Tangible Book Value | 4,321 | 4,596 | 4,863 | 4,850 | 1,577 | 355 |
Tangible Book Value Per Share | 257.30 | 274.58 | 293.83 | 301.11 | 123.26 | 30.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.